QNTM (Quantum BioPharma) Short-Term Debt : $0.77 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Quantum BioPharma Short-Term Debt?

Quantum BioPharma's Short-Term Debt for the quarter that ended in Dec. 2024 was $0.77 Mil.

Quantum BioPharma's quarterly Short-Term Debt declined from Jun. 2024 ($0.62 Mil) to Sep. 2024 ($0.30 Mil) but then increased from Sep. 2024 ($0.30 Mil) to Dec. 2024 ($0.77 Mil).

Quantum BioPharma's annual Short-Term Debt stayed the same from Dec. 2022 ($0.30 Mil) to Dec. 2023 ($0.30 Mil) but then increased from Dec. 2023 ($0.30 Mil) to Dec. 2024 ($0.77 Mil).

Quantum BioPharma Short-Term Debt Historical Data

The historical data trend for Quantum BioPharma's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum BioPharma Short-Term Debt Chart

Quantum BioPharma Annual Data

Trend

Aug15

Aug16

Aug17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

0.39

0.30

0.77

Quantum BioPharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Debt	Get a 7-Day Free Trial															0.30	0.60	0.62	0.30	0.77

Quantum BioPharma Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Quantum BioPharma Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Quantum BioPharma's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quantum BioPharma Ltd (NAS:QNTM) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

0K91:Germany QNTM:Canada

Address

55 University Avenue, Suite 1003, Toronto, ON, CAN, M5J 2H7

Website

https://www.fsdpharma.com

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.